Quick answer: ipamorelin dosage at a glance
Ipamorelin is a growth hormone secretagogue (GHSR agonist). There is no TGA-approved consumer labelling for dosing. Online forums and some clinics commonly cite 100–300 micrograms (mcg) per dose, once nightly or up to 1–3 times daily, often for 8–12 weeks. These are claims — not official recommendations — and medical supervision is important due to glucose, IGF‑1 and other safety considerations.
Dose, frequency and cycle length can change with goals (sleep, recovery, body composition), whether it’s combined with a GHRH analogue (e.g., CJC‑1295 or Sermorelin), age and labs.
Forms and strengths you may see in Australia
Ipamorelin is typically accessed via prescription-only pathways in Australia. Compounding pharmacies and authorised prescribers may offer:
- Subcutaneous injections (most common): multi‑dose vials (e.g., 2–5 mg total peptide per vial) reconstituted by the pharmacy. Doses are measured in mcg per injection.
- Nasal sprays: per‑spray amounts vary (e.g., tens to low hundreds of mcg per spray). Nasal bioavailability is variable and may be lower than injections.
Important points:
- Per‑vial strength is not the same as per‑dose amount. A 5 mg vial equals 5,000 mcg total available, split over multiple doses as directed by a prescriber.
- Do not assume an injection dose equals a nasal spray dose — the routes differ.
- Unregulated, non‑prescription sources can have incorrect strength and purity claims.
How clinicians individualise ipamorelin dosing
In a medical context, dose selection weighs expected benefit against risk and uncertainty:
- Start‑low, reassess approach: titrate within a low–moderate mcg range and review sleep, recovery, glucose and IGF‑1.
- Timing: evening/night dosing is commonly discussed for alignment with natural GH pulses and sleep.
- Frequency: once nightly vs divided doses (morning/ post‑training/ night) depends on goals and tolerability.
- Stacking: if combined with a GHRH analogue (e.g., CJC‑1295 or Sermorelin), individual doses are often reduced due to additive signalling.
Monitoring may include symptoms (hunger, fluid retention, sleep), fasting glucose/HbA1c and IGF‑1, particularly in higher‑risk groups.
Protocol claims: solo vs stacking (CJC‑1295 or Sermorelin)
Online and clinic protocols often reference:
- Ipamorelin solo: 100–300 mcg per dose, often at night.
- Stack with CJC‑1295 (no DAC): smaller, more frequent doses of both agents (e.g., pre‑bed; sometimes additional daytime doses).
- Stack with CJC‑1295 (DAC): weekly or fortnightly CJC‑1295 with nightly ipamorelin. DAC changes frequency due to longer half‑life.
- Stack with Sermorelin: similar principles to CJC‑1295 (no DAC), with caution for additive effects.
These are protocol claims, not approved instructions. Stacking should only occur under medical supervision.
Related reading: CJC‑1295 vs Ipamorelin, Ipamorelin vs Sermorelin, CJC‑1295 DAC vs No DAC.
Safety, side effects and when to seek help
Reported effects include increased hunger, transient flushing or warmth, headache, light‑headedness, water retention, tingling, sleep changes, and local injection reactions. Changes in glucose handling can occur with GH‑axis stimulation.
People generally avoid GHS use during pregnancy or breastfeeding, in active malignancy, or with uncontrolled diabetes or proliferative retinopathy. Children and adolescents require specialist care.
If you notice severe swelling, chest pain, vision changes, marked shortness of breath, or signs of infection at the injection site, seek urgent care.
Learn more: Ipamorelin Side Effects and the broader Peptide Side Effects Guide.
Units and math: mg vs mcg, vials and “per dose” amounts
Ipamorelin amounts are commonly expressed in micrograms (mcg). Vials are expressed in milligrams (mg) of total peptide available. 1 mg = 1,000 mcg.
- Example concept: A 5 mg vial contains 5,000 mcg total. If a prescriber directs 200 mcg nightly, the vial holds approximately 25 doses at that amount (5,000 ÷ 200).
- The pharmacy sets the reconstitution volume and provides calibrated syringes or device guidance so the mcg per dose corresponds to a clear measurement.
If any calculation is unclear, ask your prescriber or pharmacist before use. Do not guess volumes.
See also: Peptide Injection Guide.
Myths, red flags and dosage misinformation
- “More is better.” Higher mcg does not guarantee better outcomes and may raise risk.
- Copy‑pasting a bodybuilder’s stack. Individual factors and monitoring matter.
- Equating nasal and injection doses. Bioavailability differs.
- Unlabelled or mislabelled vials from grey‑market sellers. Purity and potency can be unreliable.
- Skipping medical checks. GH‑axis agents can influence glucose and IGF‑1.
If you’re unsure whether a dose or protocol is appropriate, get professional advice.
Legal context in Australia
Ipamorelin is generally treated as a prescription‑only medicine. Access typically requires a clinician using appropriate pathways (e.g., Authorised Prescriber or Special Access Scheme). Importing or buying without a valid prescription can result in seizure and penalties.
Read more: Is Ipamorelin Legal in Australia? and Peptide Therapy Australia Guide.
Frequently asked questions
What is a commonly cited ipamorelin dosage?
100–300 mcg per dose is frequently mentioned, often used nightly or up to 1–3 times daily. These are protocol claims and should not replace clinician direction.
When is ipamorelin usually taken?
Night dosing is commonly discussed to align with GH pulsatility and sleep. Some divide doses (morning/ post‑exercise/ night) depending on goals and tolerability.
How long are cycles?
8–12 weeks are frequently cited with reassessment. Longer courses may be considered under medical supervision with periodic breaks and monitoring.
Are higher doses better for muscle growth or fat loss?
Not necessarily. Response can plateau, and risks may increase. Individualisation and monitoring are more important than chasing large mcg numbers.
Is nasal ipamorelin effective?
Some clinics offer it, but nasal bioavailability is variable. Concentration and per‑spray amount are set by the pharmacy, and outcomes can differ from injections.
What should be monitored?
Symptoms, fasting glucose/HbA1c and IGF‑1 are commonly considered. Your clinician may add other labs based on history and goals.
Where can I learn fundamentals before deciding?
Start with What Is Ipamorelin?, Ipamorelin Benefits, Ipamorelin Side Effects, and Results Timeline.
Can I combine ipamorelin with CJC‑1295 or Sermorelin?
Some protocols do. Doses are usually reduced when stacked due to additive effects. Review our comparisons and speak with a prescriber.
Is self‑importing ipamorelin allowed?
Generally no, unless you meet specific legal pathways with a valid prescription. See legal guide.
Key takeaway
Ipamorelin dosage information online is largely based on protocol claims rather than robust, approved labelling. In Australia, lawful access and safe use depend on medical oversight, appropriate product form and strength, and monitoring of individual response and risks.
Need guidance on ipamorelin dosage and access?
Send your questions below. We’ll point you to evidence-based resources and outline typical Australian access pathways. No spam, no pressure.
By submitting this form you agree to be contacted about your enquiry. We do not sell personal data.